Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2024-04-10 00:00:00 ET · period of report 2024-04-08 · accession 0000950170-24-043385 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | 2024-04-08 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.10 | -3,435 | 95.3K | -3% | -$38.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stoock | 2024-04-08 | S | D | 3,435 | $11.10 | 95,263 | D | — | — | (F1) Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. |